{"id":17349,"date":"2022-09-20T11:33:58","date_gmt":"2022-09-20T09:33:58","guid":{"rendered":"http:\/\/mabdesign.fr\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/"},"modified":"2022-09-20T11:33:58","modified_gmt":"2022-09-20T09:33:58","slug":"covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/","title":{"rendered":"Covalab and partners receive \u20ac1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma"},"content":{"rendered":"<p><strong>Covalab and partners CimCure, Amsterdam UMC and the University of Zurich join forces on this project with total public and private fundings of \u20ac2.24M, including the Eurostars grant, to develop novel immunotherapy combining CAR-T cells and CimCure\u2019s iBoost vaccines to treat glioblastoma<\/strong><\/p>\n<p><strong>Bron, France, September 20, 2022<\/strong> \u2013 Covalab, a biotechnology company that specializes in the development and production of recombinant proteins and antibodies for diagnostics and therapeutics, today announces that together with CimCure, a Dutch biotech company focusing on the development of a novel vaccine-based immunotherapy, Amsterdam UMC (The Netherlands) and the University of Zurich (Switzerland), they have received a \u20ac1.06M ($1.08M) grant from EUREKA Eurostars. With a total budget of \u20ac2.24M ($2.28M,) including investments from the partners, the project aims to develop a new treatment against glioblastoma. CimCure B.V. is the lead coordinator of the project.<\/p>\n<p><a href=\"https:\/\/ala.com\/funding\/covalab-cimcure-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/\" target=\"_blank\" rel=\"noopener noreferrer\">To know more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Covalab and partners CimCure, Amsterdam UMC and the University of Zurich join forces on this project with total public and private fundings of \u20ac2.24M, including the Eurostars grant, to develop novel immunotherapy combining CAR-T cells and CimCure\u2019s iBoost vaccines to treat glioblastoma<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36,32],"tags":[],"class_list":["post-17349","post","type-post","status-publish","format-standard","hentry","category-news","category-our-members"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Covalab and partners receive \u20ac1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma - MabDesign<\/title>\n<meta name=\"description\" content=\"Covalab and partners CimCure, Amsterdam UMC and the University of Zurich join forces on this project with total public and private fundings of \u20ac2.24M, including the Eurostars grant, to develop novel immunotherapy combining CAR-T cells and CimCure\u2019s iBoost vaccines to treat glioblastoma\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Covalab and partners receive \u20ac1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma - MabDesign\" \/>\n<meta property=\"og:description\" content=\"Covalab and partners CimCure, Amsterdam UMC and the University of Zurich join forces on this project with total public and private fundings of \u20ac2.24M, including the Eurostars grant, to develop novel immunotherapy combining CAR-T cells and CimCure\u2019s iBoost vaccines to treat glioblastoma\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-20T09:33:58+00:00\" \/>\n<meta name=\"author\" content=\"alexis.mathias@kairios.fr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"alexis.mathias@kairios.fr\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/\"},\"author\":{\"name\":\"alexis.mathias@kairios.fr\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\"},\"headline\":\"Covalab and partners receive \u20ac1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma\",\"datePublished\":\"2022-09-20T09:33:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/\"},\"wordCount\":155,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"articleSection\":[\"News\",\"Our members\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/\",\"name\":\"Covalab and partners receive \u20ac1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"datePublished\":\"2022-09-20T09:33:58+00:00\",\"description\":\"Covalab and partners CimCure, Amsterdam UMC and the University of Zurich join forces on this project with total public and private fundings of \u20ac2.24M, including the Eurostars grant, to develop novel immunotherapy combining CAR-T cells and CimCure\u2019s iBoost vaccines to treat glioblastoma\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Covalab and partners receive \u20ac1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\",\"name\":\"alexis.mathias@kairios.fr\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"caption\":\"alexis.mathias@kairios.fr\"},\"sameAs\":[\"http:\/\/mabdesign.fr\"],\"url\":\"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Covalab and partners receive \u20ac1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma - MabDesign","description":"Covalab and partners CimCure, Amsterdam UMC and the University of Zurich join forces on this project with total public and private fundings of \u20ac2.24M, including the Eurostars grant, to develop novel immunotherapy combining CAR-T cells and CimCure\u2019s iBoost vaccines to treat glioblastoma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/","og_locale":"en_US","og_type":"article","og_title":"Covalab and partners receive \u20ac1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma - MabDesign","og_description":"Covalab and partners CimCure, Amsterdam UMC and the University of Zurich join forces on this project with total public and private fundings of \u20ac2.24M, including the Eurostars grant, to develop novel immunotherapy combining CAR-T cells and CimCure\u2019s iBoost vaccines to treat glioblastoma","og_url":"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/","og_site_name":"MabDesign","article_published_time":"2022-09-20T09:33:58+00:00","author":"alexis.mathias@kairios.fr","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"alexis.mathias@kairios.fr","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/"},"author":{"name":"alexis.mathias@kairios.fr","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135"},"headline":"Covalab and partners receive \u20ac1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma","datePublished":"2022-09-20T09:33:58+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/"},"wordCount":155,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"articleSection":["News","Our members"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/","url":"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/","name":"Covalab and partners receive \u20ac1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"datePublished":"2022-09-20T09:33:58+00:00","description":"Covalab and partners CimCure, Amsterdam UMC and the University of Zurich join forces on this project with total public and private fundings of \u20ac2.24M, including the Eurostars grant, to develop novel immunotherapy combining CAR-T cells and CimCure\u2019s iBoost vaccines to treat glioblastoma","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/covalab-and-partners-receive-e1-06m-eureka-eurostars-grant-to-develop-new-combination-therapy-for-glioblastoma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Covalab and partners receive \u20ac1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135","name":"alexis.mathias@kairios.fr","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","caption":"alexis.mathias@kairios.fr"},"sameAs":["http:\/\/mabdesign.fr"],"url":"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/17349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=17349"}],"version-history":[{"count":0,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/17349\/revisions"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=17349"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=17349"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=17349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}